BECTON, DICKINSON AND COMPANY Cash and Cash Equivalents, Period Increase (Decrease)
BECTON, DICKINSON AND COMPANY (BDX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$13.04 billion for the 12-month period ending 2018-09-30, per its 10-K filed 2018-11-21.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-11-21
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$244.00M, a 174.39% decline year-over-year.
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $134.00M, a 98.99% decline year-over-year.
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $126.00M.
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$13.05B.
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$13.04B, a 203.17% decline from fiscal 2017.
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for fiscal 2017 was $12.64B, a 10701.71% increase from fiscal 2016.
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for fiscal 2016 was $117.00M.
- BECTON, DICKINSON AND COMPANY cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$436.00M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | -$244.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21 | -$110.00M derived: sum of 2 quarters · filed 2018-11-21 | $16.00M derived: sum of 3 quarters · filed 2018-11-21 | -$13.04B 10-K · filed 2018-11-21 | ||||
| 2018-06-30 | $134.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $260.00M derived: sum of 2 quarters · filed 2018-08-02 | -$12.79B 10-Q · filed 2018-08-02 | -$12.47B derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2018-03-31 | $126.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03 | -$12.93B 10-Q · filed 2018-05-03 | -$12.60B derived: sum of 3 quarters · filed 2018-11-21 | $702.00M derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2017-12-31 | -$13.05B 10-Q · filed 2018-02-06 | -$12.73B derived: sum of 2 quarters · filed 2018-11-21 | $576.00M derived: sum of 3 quarters · filed 2018-11-21 | $205.00M derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2017-09-30 | $328.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21 | $13.63B derived: sum of 2 quarters · filed 2018-11-21 | $13.26B derived: sum of 3 quarters · filed 2018-11-21 | $12.64B 10-K · filed 2018-11-21 | ||||
| 2017-06-30 | $13.30B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $12.93B derived: sum of 2 quarters · filed 2018-08-02 | $12.31B 10-Q · filed 2018-08-02 | $12.16B derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2017-03-31 | -$371.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03 | -$993.00M 10-Q · filed 2018-05-03 | -$1.14B derived: sum of 3 quarters · filed 2018-11-21 | -$1.15B derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2016-12-31 | -$622.00M 10-Q · filed 2018-02-06 | -$767.00M derived: sum of 2 quarters · filed 2018-11-21 | -$777.00M derived: sum of 3 quarters · filed 2018-11-21 | -$663.00M derived: sum of 4 quarters · filed 2018-11-21 | ||||
| 2016-09-30 | -$145.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21 | -$155.00M derived: sum of 2 quarters · filed 2018-11-21 | -$41.00M derived: sum of 3 quarters · filed 2018-11-21 | $117.00M 10-K · filed 2018-11-21 | ||||
| 2016-06-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $104.00M derived: sum of 2 quarters · filed 2017-08-03 | $262.00M 10-Q · filed 2017-08-03 | $128.00M derived: sum of 4 quarters · filed 2017-11-22 | ||||
| 2016-03-31 | $114.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02 | $272.00M 10-Q · filed 2017-05-02 | $138.00M derived: sum of 3 quarters · filed 2017-11-22 | -$215.00M derived: sum of 4 quarters · filed 2017-11-22 | ||||
| 2015-12-31 | $158.00M 10-Q · filed 2017-02-02 | $24.00M derived: sum of 2 quarters · filed 2017-11-22 | -$329.00M derived: sum of 3 quarters · filed 2017-11-22 | -$6.96B derived: sum of 4 quarters · filed 2017-11-22 | ||||
| 2015-09-30 | -$134.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | -$487.00M derived: sum of 2 quarters · filed 2017-11-22 | -$7.12B derived: sum of 3 quarters · filed 2017-11-22 | -$436.00M 10-K · filed 2017-11-22 | ||||
| 2015-06-30 | -$353.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-04 | -$6.98B derived: sum of 2 quarters · filed 2016-08-04 | -$302.00M 10-Q · filed 2016-08-04 | -$102.00M derived: sum of 4 quarters · filed 2016-11-23 | ||||
| 2015-03-31 | -$6.63B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-06 | $51.00M 10-Q · filed 2016-05-06 | $251.00M derived: sum of 3 quarters · filed 2016-11-23 | $181.00M derived: sum of 4 quarters · filed 2016-11-23 | ||||
| 2014-12-31 | $6.68B 10-Q · filed 2016-02-05 | $6.88B derived: sum of 2 quarters · filed 2016-11-23 | $6.81B derived: sum of 3 quarters · filed 2016-11-23 | $6.86B derived: sum of 4 quarters · filed 2016-11-23 | ||||
| 2014-09-30 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-23 | $130.00M derived: sum of 2 quarters · filed 2016-11-23 | $182.00M derived: sum of 3 quarters · filed 2016-11-23 | -$29.00M 10-K · filed 2016-11-23 | ||||
| 2014-06-30 | -$70.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-06 | -$18.00M derived: sum of 2 quarters · filed 2015-08-06 | -$229.00M 10-Q · filed 2015-08-06 | -$301.00M derived: sum of 4 quarters · filed 2015-11-25 | ||||
| 2014-03-31 | $52.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | -$159.00M 10-Q · filed 2015-05-08 | -$231.00M derived: sum of 3 quarters · filed 2015-11-25 | -$293.00M derived: sum of 4 quarters · filed 2015-11-25 | ||||
| 2013-12-31 | -$211.00M 10-Q · filed 2015-02-06 | -$283.00M derived: sum of 2 quarters · filed 2015-11-25 | -$345.00M derived: sum of 3 quarters · filed 2015-11-25 | -$238.00M derived: sum of 4 quarters · filed 2015-11-25 | ||||
| 2013-09-30 | -$72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-25 | -$134.00M derived: sum of 2 quarters · filed 2015-11-25 | -$27.00M derived: sum of 3 quarters · filed 2015-11-25 | $219.00M 10-K · filed 2015-11-25 | ||||
| 2013-06-30 | -$62.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-04 | $45.00M derived: sum of 2 quarters · filed 2014-08-04 | $291.00M 10-Q · filed 2014-08-04 | $290.92M 10-Q · filed 2013-08-05 | $303.56M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-03-31 | $107.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-05 | $353.00M 10-Q · filed 2014-05-05 | $352.69M 10-Q · filed 2013-05-09 | $365.56M derived: sum of 3 quarters · filed 2015-03-13 | $184.79M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $246.00M 10-Q · filed 2014-02-10 | $246.31M 10-Q · filed 2013-02-07 | $258.56M derived: sum of 2 quarters · filed 2015-03-13 | $77.79M derived: sum of 3 quarters · filed 2015-03-13 | -$279.00M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-09-30 | $12.56M derived: 8-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$168.21M derived: sum of 2 quarters · filed 2015-03-13 | -$525.00M derived: sum of 3 quarters · filed 2015-03-13 | $496.00M 8-K · filed 2015-03-13 | $495.88M 10-K · filed 2012-11-21 | |||
| 2012-06-30 | -$180.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-05 | -$537.56M derived: sum of 2 quarters · filed 2013-08-05 | $483.44M 10-Q · filed 2013-08-05 | $500.39M derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2012-03-31 | -$356.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | $664.21M 10-Q · filed 2013-05-09 | $681.16M derived: sum of 3 quarters · filed 2013-11-27 | $1.09B derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2011-12-31 | $1.02B 10-Q · filed 2013-02-07 | $1.04B derived: sum of 2 quarters · filed 2013-11-27 | $1.45B derived: sum of 3 quarters · filed 2013-11-27 | $946.63M derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2011-09-30 | $16.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $426.40M derived: sum of 2 quarters · filed 2013-11-27 | -$74.37M derived: sum of 3 quarters · filed 2013-11-27 | -$41.00M 10-K · filed 2013-11-27 | -$40.71M 10-K · filed 2011-11-23 | |||
| 2011-06-30 | $409.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-06 | -$91.32M derived: sum of 2 quarters · filed 2012-08-06 | -$57.95M 10-Q · filed 2012-08-06 | $407.93M derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2011-03-31 | -$500.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-03 | -$467.40M 10-Q · filed 2012-05-03 | -$1.52M derived: sum of 3 quarters · filed 2012-11-21 | -$82.10M derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2010-12-31 | $33.37M 10-Q · filed 2012-02-07 | $499.25M derived: sum of 2 quarters · filed 2012-11-21 | $418.67M derived: sum of 3 quarters · filed 2012-11-21 | $67.05M derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2010-09-30 | $465.88M derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-21 | $385.30M derived: sum of 2 quarters · filed 2012-11-21 | $33.68M derived: sum of 3 quarters · filed 2012-11-21 | -$178.25M 10-K · filed 2012-11-21 | ||||
| 2010-06-30 | -$80.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-08-02 | -$432.20M derived: sum of 2 quarters · filed 2011-08-02 | -$644.14M 10-Q · filed 2011-08-02 | -$581.50M derived: sum of 4 quarters · filed 2011-11-23 | ||||
| 2010-03-31 | -$351.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-05-04 | -$563.56M 10-Q · filed 2011-05-04 | -$500.91M derived: sum of 3 quarters · filed 2011-11-23 | $287.98M derived: sum of 4 quarters · filed 2011-11-23 | ||||
| 2009-12-31 | -$211.94M 10-Q · filed 2011-02-08 | -$149.29M derived: sum of 2 quarters · filed 2011-11-23 | $639.59M derived: sum of 3 quarters · filed 2011-11-23 | $584.69M derived: sum of 4 quarters · filed 2011-11-23 | ||||
| 2009-09-30 | $62.64M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-23 | $851.53M derived: sum of 2 quarters · filed 2011-11-23 | $796.63M derived: sum of 3 quarters · filed 2011-11-23 | $563.77M 10-K · filed 2011-11-23 | ||||
| 2009-06-30 | $788.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-08-04 | $733.98M derived: sum of 2 quarters · filed 2010-08-04 | $501.12M 10-Q · filed 2010-08-04 | $595.69M derived: sum of 4 quarters · filed 2010-11-24 | ||||
| 2009-03-31 | -$54.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-05-06 | -$287.76M 10-Q · filed 2010-05-06 | -$193.20M derived: sum of 3 quarters · filed 2010-11-24 | |||||
| 2008-12-31 | -$232.86M 10-Q · filed 2010-02-08 | -$138.29M derived: sum of 2 quarters · filed 2010-11-24 | ||||||
| 2008-09-30 | $94.57M derived: 10-K 12 month − 10-Q 9 month · filed 2010-11-24 | $319.00M 10-K · filed 2010-11-24 | ||||||
| 2008-06-30 | $224.43M 10-Q · filed 2009-08-10 | |||||||
| 2007-09-30 | -$488.81M 10-K/A · filed 2010-01-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |